相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development of Isopropyl-Tailed Chalcones as a New Class of Selective MAO-B Inhibitors for the Treatment of Parkinson?s Disorder
Sunil Kumar et al.
ACS OMEGA (2023)
Aldoxime- and hydroxy-functionalized chalcones as highly potent and selective monoamine oxidase-B inhibitors
Jong Min Oh et al.
JOURNAL OF MOLECULAR STRUCTURE (2022)
Conjugated Dienones from Differently Substituted Cinnamaldehyde as Highly Potent Monoamine Oxidase-B Inhibitors: Synthesis, Biochemistry, and Computational Chemistry
Bijo Mathew et al.
ACS OMEGA (2022)
Synthesis of 4-substituted benzyl-2-triazole-linked-tryptamine-paeonol derivatives and evaluation of their selective inhibitions against butyrylcholinesterase and monoamine oxidase-B
Jong Min Oh et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)
Development of bromo- and fluoro-based α, β-unsaturated ketones as highly potent MAO-B inhibitors for the treatment of Parkinson's disease
Mohamed A. Abdelgawad et al.
JOURNAL OF MOLECULAR STRUCTURE (2022)
Development of Halogenated-Chalcones Bearing with Dimethoxy Phenyl Head as Monoamine Oxidase-B Inhibitors
Nisha Abdul Rehuman et al.
PHARMACEUTICALS (2022)
Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders
Bijo Mathew et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2021)
Halogenated Coumarin-Chalcones as Multifunctional Monoamine Oxidase-B and Butyrylcholinesterase Inhibitors
Nisha Abdul Rehuman et al.
ACS OMEGA (2021)
Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders
Vishal Payyalot Koyiparambath et al.
PHARMACEUTICS (2021)
Calycosin and 8-O-methylretusin isolated from Maackia amurensis as potent and selective reversible inhibitors of human monoamine oxidase-B
Jong Min Oh et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors
Jong Min Oh et al.
MOLECULES (2020)
Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors
Paolo Guglielmi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Rhamnocitrin isolated from Prunus padus var. seoulensis: A potent and selective reversible inhibitor of human monoamine oxidase A
Seung Cheol Baek et al.
BIOORGANIC CHEMISTRY (2019)
Selective inhibition of monoamine oxidase A by hispidol
Seung Cheol Baek et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Potent inhibition of monoamine oxidase A by decursin from Angelica gigas Nakai and by wogonin from Scutellaria baicalensis Georgi
Hyun Woo Lee et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens
Hyun Woo Lee et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
Douglas E. V. Pires et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Lateral Drug Diffusion in Human Nails
Biji B. Palliyil et al.
AAPS PHARMSCITECH (2014)
Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism
David N. Hauser et al.
NEUROBIOLOGY OF DISEASE (2013)
The spectrum of nonmotor symptoms in early Parkinson disease
Tien K. Khoo et al.
NEUROLOGY (2013)
The relevance of iron in the pathogenesis of Parkinson's disease
Jeswinder Sian-Huelsmann et al.
JOURNAL OF NEUROCHEMISTRY (2011)
A Tale on Animal Models of Parkinson's Disease
Erwan Bezard et al.
MOVEMENT DISORDERS (2011)
Entry of oximes into the brain: A review
D. E. Lorke et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Practice Parameter: Neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology
O Suchowersky et al.
NEUROLOGY (2006)
Clinical pharmacology of rasagiline: A novel, second-generation propargylamine for the treatment of Parkinson disease
JJ Chen et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Bisaryloxime ethers as potent inhibitors of transthyretin amyloid fibril formation
SM Johnson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
An algorithm (decision tree) for the management of Parkinson's disease (2001): Treatment guidelines
CW Olanow et al.
NEUROLOGY (2001)
分享论文
